Dr. Lesh is currently the CEO and founder of the data science and data privacy company Syntegra. Additionally, he serves as the executive chair of Cordance Medical, a company that uses transcranial-focused ultrasounds to treat cancer, Alzheimer’s and other brain diseases, according to a Nov. 3 Elucid news release.
“The Elucid technology is poised to become the standard of care for non-invasive diagnosis of cardiovascular disease, and I look forward to working with the company to make this a reality,” Dr. Lesh said.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
